Proto Script Pharmaceutical Overview

  • Founded
  • 2010
  • Status
  • Public
  • Employees
  • 13
  • Stock Symbol
  • PSCR
Stock Symbol

Proto Script Pharmaceutical General Information


Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Contact Information

Formerly Known As
Yanex Group
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Construction and Engineering
Other Industries
Consulting Services (B2B)
Stock Exchange
Primary Office
  • Hooft Graaflandstraat 21
  • VM
  • P7 3525 Utrecht
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Proto Script Pharmaceutical Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Proto Script Pharmaceutical Financials Summary

In Thousands,
TTM 30-Sep-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015 FY 2014 31-May-2014
EV 12,606 310,686
Revenue 605 789 881 0
EBITDA (8,378) (7,178) (69) (38)
Net Income (8,386) (7,183) (145) (38)
Total Assets 235 170 199 14
Total Debt 373 51 36
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Proto Script Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Proto Script Pharmaceutical‘s full profile, request access.

Request a free trial

Proto Script Pharmaceutical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial